img

Global Biochemical Befense Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Biochemical Befense Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Biochemical Befense Market
Global Biochemical Befense market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biochemical Befense industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Biochemical Befense key companies include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. Emergent Biosolutions, Hytest, GSK are top 3 players and held % share in total in 2023.
When considering the consumption regions, % revenue of Biochemical Befense were sold to North America, Europe and Asia Pacific in 2023. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biochemical Befense market and estimated to attract more attentions from industry insiders and investors.
Biochemical Befense can be divided into Anthrax, Smallpox, Botulism and Radiation/Nuclear, etc. Anthrax is the mainstream product in the market, accounting for % revenue share globally in 2023 and the proportion will be % in 2033.
Biochemical Befense is widely used in various fields, such as National Defense, Military and Others,, etc. National Defense provides greatest supports to the Biochemical Befense industry development. In 2023, global % revenue of Biochemical Befense went into National Defense filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biochemical Befense market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biochemical Befense market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Segment by Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

Segment by Application


National Defense
Military
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biochemical Befense introduction, etc. Biochemical Befense Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Biochemical Befense
Chapter 13Methodology and Data Sources adopted by MRA Research

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biochemical Befense Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Anthrax
1.2.3 Smallpox
1.2.4 Botulism
1.2.5 Radiation/Nuclear
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biochemical Befense Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 National Defense
1.3.3 Military
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biochemical Befense Market Perspective (2018-2033)
2.2 Global Biochemical Befense Growth Trends by Region
2.2.1 Biochemical Befense Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Biochemical Befense Historic Market Size by Region (2018-2023)
2.2.3 Biochemical Befense Forecasted Market Size by Region (2024-2033)
2.3 Biochemical Befense Market Dynamics
2.3.1 Biochemical Befense Industry Trends
2.3.2 Biochemical Befense Market Drivers
2.3.3 Biochemical Befense Market Challenges
2.3.4 Biochemical Befense Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biochemical Befense by Players
3.1.1 Global Biochemical Befense Revenue by Players (2018-2023)
3.1.2 Global Biochemical Befense Revenue Market Share by Players (2018-2023)
3.2 Global Biochemical Befense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biochemical Befense, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Biochemical Befense Market Concentration Ratio
3.4.1 Global Biochemical Befense Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biochemical Befense Revenue in 2023
3.5 Global Key Players of Biochemical Befense Head office and Area Served
3.6 Global Key Players of Biochemical Befense, Product and Application
3.7 Global Key Players of Biochemical Befense, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biochemical Befense Breakdown Data by Type
4.1 Global Biochemical Befense Historic Market Size by Type (2018-2023)
4.2 Global Biochemical Befense Forecasted Market Size by Type (2024-2033)
5 Biochemical Befense Breakdown Data by Application
5.1 Global Biochemical Befense Historic Market Size by Application (2018-2023)
5.2 Global Biochemical Befense Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biochemical Befense Market Size (2018-2033)
6.2 North America Biochemical Befense Market Size by Type
6.2.1 North America Biochemical Befense Market Size by Type (2018-2023)
6.2.2 North America Biochemical Befense Market Size by Type (2024-2033)
6.2.3 North America Biochemical Befense Market Share by Type (2018-2033)
6.3 North America Biochemical Befense Market Size by Application
6.3.1 North America Biochemical Befense Market Size by Application (2018-2023)
6.3.2 North America Biochemical Befense Market Size by Application (2024-2033)
6.3.3 North America Biochemical Befense Market Share by Application (2018-2033)
6.4 North America Biochemical Befense Market Size by Country
6.4.1 North America Biochemical Befense Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Biochemical Befense Market Size by Country (2018-2023)
6.4.3 North America Biochemical Befense Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Biochemical Befense Market Size (2018-2033)
7.2 Europe Biochemical Befense Market Size by Type
7.2.1 Europe Biochemical Befense Market Size by Type (2018-2023)
7.2.2 Europe Biochemical Befense Market Size by Type (2024-2033)
7.2.3 Europe Biochemical Befense Market Share by Type (2018-2033)
7.3 Europe Biochemical Befense Market Size by Application
7.3.1 Europe Biochemical Befense Market Size by Application (2018-2023)
7.3.2 Europe Biochemical Befense Market Size by Application (2024-2033)
7.3.3 Europe Biochemical Befense Market Share by Application (2018-2033)
7.4 Europe Biochemical Befense Market Size by Country
7.4.1 Europe Biochemical Befense Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Biochemical Befense Market Size by Country (2018-2023)
7.4.3 Europe Biochemical Befense Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biochemical Befense Market Size (2018-2033)
8.2 China Biochemical Befense Market Size by Type
8.2.1 China Biochemical Befense Market Size by Type (2018-2023)
8.2.2 China Biochemical Befense Market Size by Type (2024-2033)
8.2.3 China Biochemical Befense Market Share by Type (2018-2033)
8.3 China Biochemical Befense Market Size by Application
8.3.1 China Biochemical Befense Market Size by Application (2018-2023)
8.3.2 China Biochemical Befense Market Size by Application (2024-2033)
8.3.3 China Biochemical Befense Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Biochemical Befense Market Size (2018-2033)
9.2 Asia Biochemical Befense Market Size by Type
9.2.1 Asia Biochemical Befense Market Size by Type (2018-2023)
9.2.2 Asia Biochemical Befense Market Size by Type (2024-2033)
9.2.3 Asia Biochemical Befense Market Share by Type (2018-2033)
9.3 Asia Biochemical Befense Market Size by Application
9.3.1 Asia Biochemical Befense Market Size by Application (2018-2023)
9.3.2 Asia Biochemical Befense Market Size by Application (2024-2033)
9.3.3 Asia Biochemical Befense Market Share by Application (2018-2033)
9.4 Asia Biochemical Befense Market Size by Region
9.4.1 Asia Biochemical Befense Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Biochemical Befense Market Size by Region (2018-2023)
9.4.3 Asia Biochemical Befense Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biochemical Befense Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Biochemical Befense Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biochemical Befense Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biochemical Befense Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Biochemical Befense Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Biochemical Befense Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biochemical Befense Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biochemical Befense Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Biochemical Befense Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Biochemical Befense Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biochemical Befense Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Biochemical Befense Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biochemical Befense Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Details
11.1.2 Emergent Biosolutions Business Overview
11.1.3 Emergent Biosolutions Biochemical Befense Introduction
11.1.4 Emergent Biosolutions Revenue in Biochemical Befense Business (2018-2023)
11.1.5 Emergent Biosolutions Recent Developments
11.2 Hytest
11.2.1 Hytest Company Details
11.2.2 Hytest Business Overview
11.2.3 Hytest Biochemical Befense Introduction
11.2.4 Hytest Revenue in Biochemical Befense Business (2018-2023)
11.2.5 Hytest Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Biochemical Befense Introduction
11.3.4 GSK Revenue in Biochemical Befense Business (2018-2023)
11.3.5 GSK Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biochemical Befense Introduction
11.4.4 Sanofi Revenue in Biochemical Befense Business (2018-2023)
11.4.5 Sanofi Recent Developments
11.5 PharmAthene
11.5.1 PharmAthene Company Details
11.5.2 PharmAthene Business Overview
11.5.3 PharmAthene Biochemical Befense Introduction
11.5.4 PharmAthene Revenue in Biochemical Befense Business (2018-2023)
11.5.5 PharmAthene Recent Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Details
11.6.2 Bavarian Nordic Business Overview
11.6.3 Bavarian Nordic Biochemical Befense Introduction
11.6.4 Bavarian Nordic Revenue in Biochemical Befense Business (2018-2023)
11.6.5 Bavarian Nordic Recent Developments
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Details
11.7.2 SIGA Technologies Business Overview
11.7.3 SIGA Technologies Biochemical Befense Introduction
11.7.4 SIGA Technologies Revenue in Biochemical Befense Business (2018-2023)
11.7.5 SIGA Technologies Recent Developments
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Details
11.8.2 Arbutus Biopharma Business Overview
11.8.3 Arbutus Biopharma Biochemical Befense Introduction
11.8.4 Arbutus Biopharma Revenue in Biochemical Befense Business (2018-2023)
11.8.5 Arbutus Biopharma Recent Developments
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Details
11.9.2 DynPort Vaccine Business Overview
11.9.3 DynPort Vaccine Biochemical Befense Introduction
11.9.4 DynPort Vaccine Revenue in Biochemical Befense Business (2018-2023)
11.9.5 DynPort Vaccine Recent Developments
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Details
11.10.2 Xoma Corporation Business Overview
11.10.3 Xoma Corporation Biochemical Befense Introduction
11.10.4 Xoma Corporation Revenue in Biochemical Befense Business (2018-2023)
11.10.5 Xoma Corporation Recent Developments
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Details
11.11.2 Ichor Medical Systems Business Overview
11.11.3 Ichor Medical Systems Biochemical Befense Introduction
11.11.4 Ichor Medical Systems Revenue in Biochemical Befense Business (2018-2023)
11.11.5 Ichor Medical Systems Recent Developments
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Details
11.12.2 Aeolus Pharmaceuticals Business Overview
11.12.3 Aeolus Pharmaceuticals Biochemical Befense Introduction
11.12.4 Aeolus Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023)
11.12.5 Aeolus Pharmaceuticals Recent Developments
11.13 Achaogen
11.13.1 Achaogen Company Details
11.13.2 Achaogen Business Overview
11.13.3 Achaogen Biochemical Befense Introduction
11.13.4 Achaogen Revenue in Biochemical Befense Business (2018-2023)
11.13.5 Achaogen Recent Developments
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Details
11.14.2 Elusys Therapeutics Business Overview
11.14.3 Elusys Therapeutics Biochemical Befense Introduction
11.14.4 Elusys Therapeutics Revenue in Biochemical Befense Business (2018-2023)
11.14.5 Elusys Therapeutics Recent Developments
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Details
11.15.2 Dynavax Technologies Business Overview
11.15.3 Dynavax Technologies Biochemical Befense Introduction
11.15.4 Dynavax Technologies Revenue in Biochemical Befense Business (2018-2023)
11.15.5 Dynavax Technologies Recent Developments
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Details
11.16.2 Cleveland BioLabs Business Overview
11.16.3 Cleveland BioLabs Biochemical Befense Introduction
11.16.4 Cleveland BioLabs Revenue in Biochemical Befense Business (2018-2023)
11.16.5 Cleveland BioLabs Recent Developments
11.17 Soligenix
11.17.1 Soligenix Company Details
11.17.2 Soligenix Business Overview
11.17.3 Soligenix Biochemical Befense Introduction
11.17.4 Soligenix Revenue in Biochemical Befense Business (2018-2023)
11.17.5 Soligenix Recent Developments
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Details
11.18.2 Alnylam Pharmaceuticals Business Overview
11.18.3 Alnylam Pharmaceuticals Biochemical Befense Introduction
11.18.4 Alnylam Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023)
11.18.5 Alnylam Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biochemical Befense Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Anthrax
Table 3. Key Players of Smallpox
Table 4. Key Players of Botulism
Table 5. Key Players of Radiation/Nuclear
Table 6. Key Players of Others
Table 7. Global Biochemical Befense Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 8. Global Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 9. Global Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Biochemical Befense Market Share by Region (2018-2023)
Table 11. Global Biochemical Befense Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Biochemical Befense Market Share by Region (2024-2033)
Table 13. Biochemical Befense Market Trends
Table 14. Biochemical Befense Market Drivers
Table 15. Biochemical Befense Market Challenges
Table 16. Biochemical Befense Market Restraints
Table 17. Global Biochemical Befense Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Biochemical Befense Revenue Share by Players (2018-2023)
Table 19. Global Top Biochemical Befense by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biochemical Befense as of 2023)
Table 20. Global Biochemical Befense Industry Ranking 2021 VS 2023 VS 2023
Table 21. Global 5 Largest Players Market Share by Biochemical Befense Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Biochemical Befense, Headquarters and Area Served
Table 23. Global Key Players of Biochemical Befense, Product and Application
Table 24. Global Key Players of Biochemical Befense, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Biochemical Befense Revenue Market Share by Type (2018-2023)
Table 28. Global Biochemical Befense Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Biochemical Befense Revenue Market Share by Type (2024-2033)
Table 30. Global Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Biochemical Befense Revenue Share by Application (2018-2023)
Table 32. Global Biochemical Befense Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Biochemical Befense Revenue Share by Application (2024-2033)
Table 34. North America Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Biochemical Befense Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Biochemical Befense Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Biochemical Befense Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 39. North America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Biochemical Befense Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Biochemical Befense Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Biochemical Befense Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 46. Europe Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Biochemical Befense Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Biochemical Befense Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Biochemical Befense Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Biochemical Befense Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Biochemical Befense Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 57. Asia Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Biochemical Befense Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biochemical Befense Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Biochemical Befense Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biochemical Befense Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 64. Middle East, Africa, and Latin America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 66. Emergent Biosolutions Company Details
Table 67. Emergent Biosolutions Business Overview
Table 68. Emergent Biosolutions Biochemical Befense Product
Table 69. Emergent Biosolutions Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 70. Emergent Biosolutions Recent Developments
Table 71. Hytest Company Details
Table 72. Hytest Business Overview
Table 73. Hytest Biochemical Befense Product
Table 74. Hytest Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 75. Hytest Recent Developments
Table 76. GSK Company Details
Table 77. GSK Business Overview
Table 78. GSK Biochemical Befense Product
Table 79. GSK Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 80. GSK Recent Developments
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Biochemical Befense Product
Table 84. Sanofi Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 85. Sanofi Recent Developments
Table 86. PharmAthene Company Details
Table 87. PharmAthene Business Overview
Table 88. PharmAthene Biochemical Befense Product
Table 89. PharmAthene Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 90. PharmAthene Recent Developments
Table 91. Bavarian Nordic Company Details
Table 92. Bavarian Nordic Business Overview
Table 93. Bavarian Nordic Biochemical Befense Product
Table 94. Bavarian Nordic Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 95. Bavarian Nordic Recent Developments
Table 96. SIGA Technologies Company Details
Table 97. SIGA Technologies Business Overview
Table 98. SIGA Technologies Biochemical Befense Product
Table 99. SIGA Technologies Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 100. SIGA Technologies Recent Developments
Table 101. Arbutus Biopharma Company Details
Table 102. Arbutus Biopharma Business Overview
Table 103. Arbutus Biopharma Biochemical Befense Product
Table 104. Arbutus Biopharma Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 105. Arbutus Biopharma Recent Developments
Table 106. DynPort Vaccine Company Details
Table 107. DynPort Vaccine Business Overview
Table 108. DynPort Vaccine Biochemical Befense Product
Table 109. DynPort Vaccine Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 110. DynPort Vaccine Recent Developments
Table 111. Xoma Corporation Company Details
Table 112. Xoma Corporation Business Overview
Table 113. Xoma Corporation Biochemical Befense Product
Table 114. Xoma Corporation Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 115. Xoma Corporation Recent Developments
Table 116. Ichor Medical Systems Company Details
Table 117. Ichor Medical Systems Business Overview
Table 118. Ichor Medical Systems Biochemical Befense Product
Table 119. Ichor Medical Systems Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 120. Ichor Medical Systems Recent Developments
Table 121. Aeolus Pharmaceuticals Company Details
Table 122. Aeolus Pharmaceuticals Business Overview
Table 123. Aeolus Pharmaceuticals Biochemical Befense Product
Table 124. Aeolus Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 125. Aeolus Pharmaceuticals Recent Developments
Table 126. Achaogen Company Details
Table 127. Achaogen Business Overview
Table 128. Achaogen Biochemical Befense Product
Table 129. Achaogen Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 130. Achaogen Recent Developments
Table 131. Elusys Therapeutics Company Details
Table 132. Elusys Therapeutics Business Overview
Table 133. Elusys Therapeutics Biochemical Befense Product
Table 134. Elusys Therapeutics Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 135. Elusys Therapeutics Recent Developments
Table 136. Dynavax Technologies Company Details
Table 137. Dynavax Technologies Business Overview
Table 138. Dynavax Technologies Biochemical Befense Product
Table 139. Dynavax Technologies Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 140. Dynavax Technologies Recent Developments
Table 141. Cleveland BioLabs Company Details
Table 142. Cleveland BioLabs Business Overview
Table 143. Cleveland BioLabs Biochemical Befense Product
Table 144. Cleveland BioLabs Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 145. Cleveland BioLabs Recent Developments
Table 146. Soligenix Company Details
Table 147. Soligenix Business Overview
Table 148. Soligenix Biochemical Befense Product
Table 149. Soligenix Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 150. Soligenix Recent Developments
Table 151. Alnylam Pharmaceuticals Company Details
Table 152. Alnylam Pharmaceuticals Business Overview
Table 153. Alnylam Pharmaceuticals Biochemical Befense Product
Table 154. Alnylam Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023) & (US$ Million)
Table 155. Alnylam Pharmaceuticals Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biochemical Befense Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Biochemical Befense Market Share by Type: 2023 VS 2033
Figure 3. Anthrax Features
Figure 4. Smallpox Features
Figure 5. Botulism Features
Figure 6. Radiation/Nuclear Features
Figure 7. Others Features
Figure 8. Global Biochemical Befense Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 9. Global Biochemical Befense Market Share by Application: 2023 VS 2033
Figure 10. National Defense Case Studies
Figure 11. Military Case Studies
Figure 12. Others Case Studies
Figure 13. Biochemical Befense Report Years Considered
Figure 14. Global Biochemical Befense Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Biochemical Befense Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 16. Global Biochemical Befense Market Share by Region: 2023 VS 2033
Figure 17. Global Biochemical Befense Market Share by Players in 2023
Figure 18. Global Top Biochemical Befense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biochemical Befense as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Biochemical Befense Revenue in 2023
Figure 20. North America Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Biochemical Befense Market Share by Type (2018-2033)
Figure 22. North America Biochemical Befense Market Share by Application (2018-2033)
Figure 23. North America Biochemical Befense Market Share by Country (2018-2033)
Figure 24. United States Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Biochemical Befense Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Biochemical Befense Market Share by Type (2018-2033)
Figure 28. Europe Biochemical Befense Market Share by Application (2018-2033)
Figure 29. Europe Biochemical Befense Market Share by Country (2018-2033)
Figure 30. Germany Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Biochemical Befense Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Biochemical Befense Market Share by Type (2018-2033)
Figure 38. China Biochemical Befense Market Share by Application (2018-2033)
Figure 39. Asia Biochemical Befense Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Biochemical Befense Market Share by Type (2018-2033)
Figure 41. Asia Biochemical Befense Market Share by Application (2018-2033)
Figure 42. Asia Biochemical Befense Market Share by Region (2018-2033)
Figure 43. Japan Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Biochemical Befense Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Biochemical Befense Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Biochemical Befense Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Biochemical Befense Market Share by Country (2018-2033)
Figure 53. Brazil Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Biochemical Befense Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Emergent Biosolutions Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 60. Hytest Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 61. GSK Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 63. PharmAthene Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 64. Bavarian Nordic Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 65. SIGA Technologies Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 66. Arbutus Biopharma Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 67. DynPort Vaccine Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 68. Xoma Corporation Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 69. Ichor Medical Systems Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 70. Aeolus Pharmaceuticals Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 71. Achaogen Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 72. Elusys Therapeutics Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 73. Dynavax Technologies Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 74. Cleveland BioLabs Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 75. Soligenix Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 76. Alnylam Pharmaceuticals Revenue Growth Rate in Biochemical Befense Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed